Agrawal, U. ., Kumari, N. ., Vasudeva, P. ., Mohanty, N. ., & Saxena, S. . (2018). Overexpression of COX2 indicates poor survival in urothelial bladder cancer. Annals of Diagnostic Pathology, 34, 50-55. https://doi.org/10.1016/j.anndiagpath.2018.01.008

Kumari, N. ., Agrawal, U. ., Mishra, A. ., Kumar, A. ., Vasudeva, P. ., Mohanty, N. ., & Saxena, S. . (2017). Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, 39(4), 1010428317697552. https://doi.org/10.1177/1010428317697552

Agrawal, U. ., Kumari, N. ., Mishra, A. ., Vasudeva, P. ., Kumar, A. ., Mohanty, N. ., & Saxena, S. . (2016). Immune signature of urothelial cancer associated with grade, recurrence, and invasion. Urologic Oncology, 34(9), 418.e17-26. https://doi.org/10.1016/j.urolonc.2016.04.013

Kumari, N. ., Saxena, S. ., & Agrawal, U. . (2015). Exosomal protein interactors as emerging therapeutic targets in urothelial bladder cancer. Journal of the Egyptian National Cancer Institute, 27(2), 51-8. https://doi.org/10.1016/j.jnci.2015.02.002